These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22990327)

  • 1. Effect of cardiovascular drug classes on all-cause mortality among atrial fibrillation patients treated in primary care in Sweden: a cohort study.
    Wändell P; Carlsson AC; Sundquist K; Johansson SE; Sundquist J
    Eur J Clin Pharmacol; 2013 Feb; 69(2):279-87. PubMed ID: 22990327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy and mortality in atrial fibrillation--a cohort of men and women 75 years or older in Sweden.
    Wändell PE; Carlsson AC; Sundquist J; Johansson SE; Bottai M; Sundquist K
    Age Ageing; 2015 Mar; 44(2):232-8. PubMed ID: 25324331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prescribed antihypertensives and other cardiovascular drugs on mortality in patients with atrial fibrillation and hypertension: a cohort study from Sweden.
    Carlsson AC; Wändell P; Sundquist K; Johansson SE; Sundquist J
    Hypertens Res; 2014 Jun; 37(6):553-9. PubMed ID: 24599014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socioeconomic factors and mortality in patients with atrial fibrillation-a cohort study in Swedish primary care.
    Wändell P; Carlsson AC; Gasevic D; Holzmann MJ; Ärnlöv J; Sundquist J; Sundquist K
    Eur J Public Health; 2018 Dec; 28(6):1103-1109. PubMed ID: 29746622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neighbourhood socio-economic status and all-cause mortality in adults with atrial fibrillation: A cohort study of patients treated in primary care in Sweden.
    Wändell P; Carlsson AC; Gasevic D; Sundquist J; Sundquist K
    Int J Cardiol; 2016 Jan; 202():776-81. PubMed ID: 26474468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression or anxiety and all-cause mortality in adults with atrial fibrillation--A cohort study in Swedish primary care.
    Wändell P; Carlsson AC; Gasevic D; Wahlström L; Sundquist J; Sundquist K
    Ann Med; 2016; 48(1-2):59-66. PubMed ID: 26758363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive drugs and relevant cardiovascular pharmacotherapies and the risk of incident dementia in patients with atrial fibrillation.
    Wändell P; Carlsson AC; Sundquist J; Sundquist K
    Int J Cardiol; 2018 Dec; 272():149-154. PubMed ID: 30072151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase.
    Proietti M; Laroche C; Nyvad O; Haberka M; Vassilikos VP; Maggioni AP; Boriani G; Lip GYH;
    Int J Cardiol; 2017 Dec; 248():166-172. PubMed ID: 28859841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cardiovascular drugs on mortality in atrial fibrillation and chronic heart failure.
    Wändell P; Carlsson AC; Sundquist J; Johansson SE; Bottai M; Sundquist K
    Scand Cardiovasc J; 2014 Oct; 48(5):291-8. PubMed ID: 25022789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cardiovascular pharmacotherapies on incident dementia in patients with atrial fibrillation: A cohort study of all patients above 45 years diagnosed with AF in hospitals in Sweden.
    Wändell P; Carlsson AC; Li X; Sundquist J; Sundquist K
    Int J Cardiol; 2019 Dec; 297():55-60. PubMed ID: 31619361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin treatment and risk of myocardial infarction - A cohort study of patients with atrial fibrillation treated in primary health care.
    Wändell P; Carlsson AC; Holzmann MJ; Ärnlöv J; Johansson SE; Sundquist J; Sundquist K
    Int J Cardiol; 2016 Oct; 221():789-93. PubMed ID: 27428322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing Management and Outcomes in Men and Women With Nonvalvular Atrial Fibrillation: Data From a Population-Based Cohort.
    Arnson Y; Hoshen M; Berliner Senderey A; Reges O; Balicer R; Leibowitz M; Avgil Tsadok M; Haim M
    JACC Clin Electrophysiol; 2018 May; 4(5):604-614. PubMed ID: 29798787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care.
    Carlsson AC; Wändell P; Gasevic D; Sundquist J; Sundquist K
    Int J Cardiol; 2015; 187():547-52. PubMed ID: 25863300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between antithrombotic treatment and hemorrhagic stroke in patients with atrial fibrillation-a cohort study in primary care.
    Wändell P; Carlsson AC; Holzmann M; Ärnlöv J; Johansson SE; Sundquist J; Sundquist K
    Eur J Clin Pharmacol; 2017 Feb; 73(2):215-221. PubMed ID: 27826643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between relevant cardiovascular pharmacotherapies and incident heart failure in patients with atrial fibrillation: a cohort study in primary care.
    Wändell P; Carlsson AC; Holzmann MJ; Ärnlöv J; Sundquist J; Sundquist K
    J Hypertens; 2018 Sep; 36(9):1929-1935. PubMed ID: 29870433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin treatment for patients with paroxysmal atrial fibrillation.
    Watanabe E; Yamashita T; Suzuki S; Saikawa T; Hirai M; Yamazaki T; Ohtsu H; Ogawa S;
    Int Heart J; 2011; 52(2):103-6. PubMed ID: 21483169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use and mortality in atrial fibrillation: A systematic review and meta-analysis of 100,287 patients.
    Pastori D; Baratta F; Di Rocco A; Farcomeni A; Del Ben M; Angelico F; Violi F; Pignatelli P; Lip GYH
    Pharmacol Res; 2021 Mar; 165():105418. PubMed ID: 33450384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of statins and antihypertensive medications in relation to risk of long-standing persistent atrial fibrillation.
    Thacker EL; Jensen PN; Psaty BM; McKnight B; Longstreth WT; Dublin S; Newton KM; Smith NL; Siscovick DS; Heckbert SR
    Ann Pharmacother; 2015 Apr; 49(4):378-86. PubMed ID: 25628466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Mortality and Nonfatal Cardiovascular Events in Adults With Atrial Fibrillation With Versus Without Levothyroxine Treatment.
    Wändell P; Carlsson AC; Holzmann MJ; Ärnlöv J; Sundquist J; Sundquist K
    Am J Cardiol; 2017 Dec; 120(11):1974-1979. PubMed ID: 28941600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prescribed antithrombotics and other cardiovascular pharmacotherapies on all-cause mortality in patients with diabetes and atrial fibrillation - a cohort study from Sweden using propensity score analyses.
    Wändell P; Carlsson AC; Sundquist J; Johansson SE; Bottai M; Sundquist K
    Diabetol Metab Syndr; 2014 Jan; 6(1):2. PubMed ID: 24397919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.